Literature DB >> 16650442

Oral-tolerance induction in diet-induced obese mice.

Natsuko Mito1, Tomoko Kaburagi, Haruka Yoshino, Atsuko Imai, Kazuto Sato.   

Abstract

OBJECTIVE: It is known that immune functions are altered in various ways by obesity. However, changes in the intestinal immune system resulting from obesity remain poorly understood. Oral tolerance is a system that suppresses antigen specific immune responses to orally administrated antigens. The intestinal immune system is intimately associated with the oral tolerance system, that acts to prevent allergic and inflammatory diseases. In this study we investigated the effect of obesity on induction of oral tolerance to ovalbumin (OVA) in an animal model of obesity. RESEARCH METHODS AND PROCEDURES: Obese mice induced by a high fat diet and control mice were allowed free access for 3 days to a 1%-ovalbumin (OVA) solution in drinking water. After continuous feeding of the antigen, all the mice were immunized by two intraperitoneal injections of OVA administered 7 days apart.
RESULTS: In the control mice, induction of oral tolerance caused an increase in antigen specific IgG1 levels and a decrease in IgG2a levels. In contrast, the IgG1/IgG2a ratio was reversed in obese mice. OVA-specific IL-2 production was suppressed by antigen feeding in both the control and obese mice; however, suppression of OVA-specific IL-10 was observed only in the control mice. Although OVA-specific IgA and IgM were not affected by antigen feeding, the obese groups of mice had significantly lower titers of antibodies. DISCUSSION: These findings suggest that obesity may affect induction of oral tolerance following antigen feeding and that these changes may be related to the inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650442     DOI: 10.1016/j.lfs.2006.03.015

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.

Authors:  Daniel A Winer; Shawn Winer; Melissa H Y Chng; Lei Shen; Edgar G Engleman
Journal:  Cell Mol Life Sci       Date:  2013-10-15       Impact factor: 9.261

2.  CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.

Authors:  Britnie R James; Kristin G Anderson; Erik L Brincks; Tamara A Kucaba; Lyse A Norian; David Masopust; Thomas S Griffith
Journal:  Cancer Immunol Immunother       Date:  2014-08-21       Impact factor: 6.968

Review 3.  Adaptive immunity and adipose tissue biology.

Authors:  Denise A Kaminski; Troy D Randall
Journal:  Trends Immunol       Date:  2010-10       Impact factor: 16.687

Review 4.  Metabolic syndrome - Removing roadblocks to therapy: Antigenic immunotherapies.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Mol Metab       Date:  2014-01-21       Impact factor: 7.422

5.  B lymphocytes as emerging mediators of insulin resistance.

Authors:  D A Winer; S Winer; L Shen; M H Y Chng; E G Engleman
Journal:  Int J Obes Suppl       Date:  2012-07

Review 6.  Hormonal Dysregulation and Unbalanced Specialized Pro-Resolving Mediator Biosynthesis Contribute toward Impaired B Cell Outcomes in Obesity.

Authors:  Miranda Crouch; Abrar Al-Shaer; Saame Raza Shaikh
Journal:  Mol Nutr Food Res       Date:  2020-04-01       Impact factor: 5.914

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.